MedTrace Logo

Personalising Psychotherapy for Chronic Primary Pain Using Network Analysis

NCT06179784 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-12-22

No results posted yet for this study

Summary

The goal of this single case experimental design study with multiple baselines is to use network analysis to personalise cognitive behaviour therapy for chronic primary pain (CPP) and base the selection of individual treatment targets and interventions on data to avoid cognitive biases of the clinicians. The main questions it aims to answer are:

* Is the study procedure accepted by and feasible for CPP patients as well as their therapists?
* Does the personalised psychotherapy with databased clinical decisionmaking lead to significant improvement?

Participants will go through several study phases:

* Pretest and informational meeting with study management
* Baseline 1: answering a questionnaire six times a day for 21 days in daily life on their mobilephone (EMA); this data will be used for the calculation of a network for each participant, that in turn will be used to select the treatment target and according treatment intervention as suggested by an algorithmic decisiontool
* Probatory therapy phase: three weekly sessions with therapist; questionnaire three times a week
* Baseline 2: questionnaire three times a week
* Therapy phase: up to ten sessions with therapist; questionnaire three times a week
* Post phase: posttest, two weeks of three weekly assessments, then another 21 days EMA; two monthly booster sessions with therapist
* Follow-up: posttest and meeting with study management

Conditions

  • Chronic Primary Pain

Interventions

BEHAVIORAL

Cognitive Behaviour Therapy including third-wave

All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behaviour Therapy including methods from the third wave like Acceptance and Commitment Therapy or Mindful Selfcompassion.

Sponsors & Collaborators

  • Prof. Dr. Julia Glombiewski

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-17
Primary Completion
2025-08-08
Completion
2025-08-08

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06179784 on ClinicalTrials.gov